REG - HeiQ PLC - Trading Update and Acquisition

HeiqAnnouncement

04/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230104:nRSD5801La&default-theme=true

RNS Number : 5801L  HeiQ PLC  04 January 2023

4 January 2023

 

HeiQ Plc

("HeiQ" or "the Company")

 

Trading Update & Acquisition

 

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene
technologies, announces a trading update for its year ended 31 December 2022
(FY 2022), as well as the acquisition of Tarn-Pure Holdings Ltd.

Trading update

As reported in the Company's interim results on 13 September 2022, HeiQ made
solid progress in the first half of the financial year, reporting a 17%
increase in revenues, despite the continued challenging global market
conditions. The Company has continued to execute on its long-term growth
strategy, focussing on strengthening its innovation and differentiation
capabilities.

As previously announced, HeiQ has historically demonstrated significantly
stronger sales in the second half of the year, underpinned by consumer driven
seasonality of its core products. The board previously commented that it
remained cautiously optimistic in a strong trading performance during the
second half of the year such that trading for FY 2022 would be in line with
market guidance. This view was supported through the anticipation of securing
additional revenues from new products and innovations, including from
milestone achievements related to HeiQ AeoniQ, the world's first climate
positive cellulosic fiber aiming to replace polyester.

Whilst trading during the third quarter of FY 2022 remained reasonable,
worsening macroeconomic conditions into Q4 have resulted in a significant
deterioration in consumer demand which, in turn, impacted the Group's sales
during the period. This reduction in sales has been compounded by brands
having increased their levels of inventory to all-time highs after the
pandemic due to persisting supply chain concerns. HeiQ's customer base had up
to 70% less demand in Q4. HeiQ's sales in China suffered especially, due to
pandemic related regional lockdowns and half of the forecasted annual sales
did not materialize.

Brands have become more hesitant to invest in innovations at this particular
time. As such, revenues planned for Q4 2022 from new partner brands related to
milestone achievements have been delayed and are expected to materialize in FY
2023 only. Accordingly, the Company expects that Group revenues for FY 2022
will be approximately 20% below market expectations at between US$ 54m to US$
55m. Gross margin is also expected to be below market expectations at ~47% -
48%. As a consequence, the Company expects a loss before tax of between US$
2.5m and US$ 3.5m for the same period. All FY 2022 numbers are subject to
audit review and considered "preliminary".

The Industry expects global markets to continue to experience low demand for
at least another six to nine months. The Company also expects trading for FY
2023 to be below market guidance, with anticipated sales and gross margins
maintained at FY 2022 levels. Given the macroeconomic headwinds the Company
has started to implement cost savings and will continue to review and adapt
its cost basis with the objective of returning to profit before tax in FY
2023.

While the macroeconomic headwinds have prevented the Company from achieving
its financial targets, this was not the case with the progress made in
blockbuster technologies; In particular, HeiQ succeeded in:

-      building a first pilot commercialization line for HeiQ AeoniQ, the
world's first cellulosic climate positive fibre, and secured Hugo Boss as an
investor and first launch partner in January 2023.

-      securing the recommendation by the Robert Koch Institute for HeiQ
Synbio probiotic cleaners versus disinfectants for hospitals following the
publication by the Charitè Hospital Berlin.

-      selling the first samples of HeiQ GrapheneX membrane to leading
players in the production of batteries and handheld mobile devices and
ordering the first pilot commercialization plant.

-      developing the first transparent foils with HeiQ ECOS silver
nanowires, conferring infrared reflection for transparent insulation of
building windows and stealth technology for defence.

 

Acquisition

The Company also announces that HeiQ Materials AG, Switzerland, a 100%
subsidiary of HeiQ Plc, has signed an agreement to acquire the entire issued
share capital of Tarn-Pure Holdings Ltd ("Tarn-Pure"). Tarn-Pure is a UK-based
intellectual property company holding critical EU and UK regulatory
registrations to sell elemental copper and elemental silver for use in
disinfecting hygiene applications. HeiQ generates significant silver
technology sales and the acquired regulatory asset will enable it to further
increase these sales. Tarn-Pure expects to report total revenues of
approximately US$ 400,000 for the FY 2022, which are mostly derived from
royalty sales.

Due to European Union regulatory changes in 2022, several high-volume organic
and inorganic biocides are being phased out. Elemental copper and silver have
received a favourable regulatory risk assessment and are poised to replace the
phased-out biocides. HeiQ expects strong growth in the use of the safe and
effective antimicrobials copper and silver, which are used in coatings,
plastics, textiles, and water purification. With the acquisition of Tarn-Pure,
HeiQ positions itself as the key supplier of elemental copper and elemental
silver to the wider hygiene industry.

To acquire Tarn-Pure, HeiQ will pay its vendors a consideration of
approximately £850,000, subject to adjustments for cash, working capital and
debt positions as of closing date. The consideration is agreed to be paid 50%
in cash and 50% through the issue of new ordinary shares in HeiQ Plc to the
vendors at a significant premium to the closing market price as of 3 January
2023. The Company accordingly expects to issue approximately 613,000 new
ordinary shares and the exact number of shares to be issued will be announced
upon closing of the transaction, which is expected later this month.

HeiQ's EVP Tom Ellefsen said:

 "The HeiQ group has an impressive product range of antimicrobials. Thanks to
the recent acquisitions of RAS Ltd., Life Materials Ltd. and Touchguard's
Patents, HeiQ has built a unique capability to serve the hygiene industry with
effective solutions. The acquisition of Tarn-Pure's regulatory asset
strengthens HeiQ's ability to offer the market access to Europe and the UK for
products containing antimicrobial copper and silver. I expect our sales in
silver and copper technologies to significantly grow in 2023 thanks to now one
of the strongest regulatory portfolios in the market."

 

This announcement contains inside information.

 

For further information, please contact:

 HeiQ Plc                                                +41 56 250 68 50

 Carlo Centonze (CEO)
 Cenkos Securities plc (Joint Broker)                    +44 (0) 207 397 8900

 Stephen Keys / Callum Davidson
 SEC Newgate (Media Enquiries)                           +44 (0) 20 3757 6882

 Elisabeth Cowell / Axaule Shukanayeva / Molly Gretton   HeiQ@s (mailto:HeiQ@secnewgate.co.uk) ecnewgate (mailto:HeiQ@secnewgate.co.uk)
                                                         .co.uk (mailto:HeiQ@secnewgate.co.uk)

 

About HeiQ

HeiQ is focused on improving the lives of billions of people world-wide by
innovating the materials people use every day. HeiQ has strong IP which is at
the forefront of global technology in the $10 billion antimicrobial fabrics
market, $24 billion textile chemicals market, the $50 billion probiotics
market and the $150 billion man-made fibers market. It has also moved into the
medical device, healthcare and hygiene coatings markets, to help make
hospitals and healthcare environments more hygienic. HeiQ aims to deliver
growth for its shareholders through a combination of increased sales of its
core products and by entering additional lucrative markets through disruptive
innovations and M&A.

HeiQ has created some of the most effective, durable and high-performance
technologies in the market today, which cool, warm, dry, repel, purify, and
destroy viruses. Since 2005, HeiQ has developed over 200 technologies in
partnership with 300 major brands and it has a significant R&D pipeline
containing over 50 projects. The Company has won multiple awards and gained a
strong reputation for the ESG & sustainable downstream effect of its
innovations. HeiQ is the only company to have won the Swiss Technology award
twice. It has also won the Swiss Environmental award with an innovation that
saves energy and water consumption during the textile manufacturing process.

Led by an experienced leadership team, HeiQ researches new solutions for
partners, delivers scaled up manufacturing from its sites across the world and
helps partners market the product to end consumers - aiming for lab to
consumer in months.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUPUGWGUPWPPW